Skip to main content
Journal of Virology logoLink to Journal of Virology
. 2002 Jan;76(1):178–184. doi: 10.1128/JVI.76.1.178-184.2002

Furin Is Involved in Baculovirus Envelope Fusion Protein Activation

Marcel Westenberg 1, Hualin Wang 1,2, Wilfred F J IJkel 1, Rob W Goldbach 1, Just M Vlak 1, Douwe Zuidema 1,*
PMCID: PMC135720  PMID: 11739683

Abstract

The Spodoptera exigua multicapsid nucleopolyhedrovirus (SeMNPV) Se8 gene was recently shown to encode the viral envelope fusion (F) protein. A 60-kDa C-terminal subunit (F1) of the 76-kDa primary translation product of this gene was found to be the major envelope protein of SeMNPV budded virus (BV) (W. F. J. IJkel, M. Westenberg, R. W. Goldbach, G. W. Blissard, J. M. Vlak, and D. Zuidema, Virology 275:30–41, 2000). A specific inhibitor was used to show that furin is involved in cleavage of the precursor envelope fusion (F0) protein. BV produced in the presence of the inhibitor possesses the uncleaved F0 protein, while an F protein with a mutation in the furin cleavage site was translocated to the plasma membrane but lost its fusogenic activity. These results indicate that cleavage of F0 is required to activate the SeMNPV F protein and is necessary for BV infectivity. Specific antibodies against F1 and against the putative N terminus (F2) of the primary translation product were used to show that the F protein is BV specific and that BVs contain both the 60- (F1) and 21-kDa (F2) cleavage products. In nonreducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis both subunits migrate as a single 80-kDa protein, indicating that the subunits remain associated by a disulfide linkage. In addition, the presence of the F protein predominately as a monomer suggests that disulfide links are not involved in oligomerization. Thus, the envelope fusion protein from group II nucleopolyhedroviruses of baculoviruses has properties similar to those of proteins from a number of vertebrate viruses.


The Baculoviridae are a family of large, enveloped double-stranded DNA viruses exclusively pathogenic to arthropods, predominantly insects in the order Lepidoptera (1). Baculoviruses of the genus Nucleopolyhedrovirus (NPV) produce two distinct virion phenotypes: the occlusion-derived virus (ODV) and the budded virus (BV) phenotypes (53). ODVs are released from occlusion bodies due to the alkaline environment of the insect gut and are able to infect the midgut epithelial cells by direct membrane fusion (12, 13, 19). BVs infect insect cells via receptor-mediated endocytosis and are responsible for the systemic spread of the virus in the insect (17, 54). Upon acidification of the endosome, the viral and endosomal membranes fuse, thereby allowing entry of the nucleocapsid into the cytoplasm (4, 17). For group I NPVs, e.g., Autographa californica AcMNPV, Bombyx mori BmNPV, and Orgyia pseudotsugata OpMNPV, this fusion is mediated by envelope fusion protein GP64 (4, 24, 39). This protein is also required for efficient budding of newly synthesized nucleocapsids at the plasma membrane (30, 33). Baculoviruses belonging to group II NPVs, e.g., SeMNPV (21), Lymantria dispar LdMNPV (26), and Helicoverpa armigera HaSNPV (7), conspicuously lack a GP64-like protein.

Recently, a novel type of envelope fusion (F) protein was identified in BVs of group II NPVs, notably in SeMNPV (22) and LdMNPV (37). For SeMNPV this F protein is encoded by ORF8 (Se8) (21). A C-terminal 60-kDa subunit of the 76-kDa primary translation product was found to be the major envelope protein of SeMNPV BV. Several protein bands with molecular sizes in the 15- to 17-kDa range were found (22), and one of these could represent the N-terminal subunit of the F protein. The involvement of furin in the cleavage was hypothesized on the basis of the presence of furin-like proprotein convertase site RSKR immediately upstream of the N terminus of the 60-kDa cleavage product (22).

Cleavage of viral fusion proteins seems to be a general mechanism to activate these proteins and to produce infectious viruses. The cleavage takes place in front of a hydrophobic sequence, the “fusion peptide.” Exposure to low pH or receptor binding triggers a conformational change whereby the fusion peptide is believed to translocate to the top of the molecule and to insert into the target membrane (25). A number of fusion proteins of vertebrate viruses are cleaved by furin. These include human cytomegalovirus glycoprotein B (50), human parainfluenza virus type 3 F (36), Ebola virus glycoprotein GP (52), and avian influenza virus hemagglutinin (HA) (47). The furin-mediated cleavage yields in all these cases two subunits that are disulfide linked. Furin is localized in the trans-Golgi network (51) and cleaves after the consensus cleavage site R-X-R/K-R (20, 32). The arginine immediately upstream of the cleavage site is the most essential amino acid (32). For Ebola virus envelope protein GP it has been shown that changing this arginine into a lysine results in an uncleaved precursor protein (52). Cleavage of some fusion proteins can be inhibited by peptidyl-chloroalkylketones containing the R-X-K/R-R motif, which specifically bind to the catalytic site of furin (10, 15, 40, 47).

In this paper evidence is provided by using a furin inhibitor and mutational analysis of the furin-like proprotein convertase site that cleavage of the SeMNPV BV F protein is mediated by furin and that this cleavage is required to activate the SeMNPV F protein to render infectious BVs. Furthermore, whether both subunits of the primary translation product are present in the SeMNPV BV and whether these remain associated to each other are investigated.

MATERIALS AND METHODS

Cells, insects, and viruses.

Spodoptera frugiperda cell line IPLB-SF-21 (48) and Spodoptera exigua cell line Se301 (16) were cultured at 27°C in plastic tissue culture flasks (Nunc) in Grace’s insect medium, pH 5.9 to 6.1 (Gibco-BRL), supplemented with 10% fetal bovine serum (FBS). A culture of S. exigua insects was maintained as described by Smits and Vlak (46). The SeMNPV isolate (11) was originally obtained from B. A. Federici (Department of Entomology, University of California) and was called SeMNPV-US1 (31). The AcMNPV-E2 strain (45) was originally obtained from M. D. Summers (Texas A&M University, College Station, Tex.).

Plasmid constructions.

The regions coding for amino acids 1 (M) to 149 (R) (F2) and amino acids 150 (G) to 579 (G) (F1Δ580-665) of ORF8 in the SeMNPV genome were amplified by high-fidelity Expand long-template PCR (Boehringer Mannheim) from plasmid pSeBglII-H (21). Primers used to amplify F1Δ580-665 were 5′-TTTGGATCCCGGCCTTTTTAATTTTATGG-3′ (underlined nucleotides generated a BamHI site) and 5′-AATAAGCT TAACCGATGCTGGAAAACCACGAAGAC-3′ (underlined and boldface nucleotides generated a HindIII site and a translation stop codon, respectively). Primers used for amplifying F2 were 5′-TTGGGATCCTATGCTGCGTTTTAAAGTGATTGTG-3′ (underlined nucleotides generated a BamHI site) and 5′-ATTAAGCTTAGCGTTTAGAGCGTCTTTTCGTCG-3′ (underlined and boldface nucleotides generated a HindIII site and a translation stop codon, respectively). The PCR products were cloned into the BamHI and HindIII cloning sites of expression vector pET28a (Novagen) to generate pET28-SeF1Δ580-665 and pET28-SeF2.

PCR-based site-directed mutation of the arginine (R149) immediately upstream of the convertase cleavage site into a lysine (K149) was performed according to the method of Sharrocks and Shaw (43). The 5′ primer 5′-TTATGGATCCATGCTGCGTTTTAAAGTGATTGTG-3′ and the 3′ mutagenic primer 5′-CCCATAAAATTAAAAAGGCCCTTTTTAGAGCGTCTTTTCGTCG-3′ (underlined nucleotides generated the mutation) were used in conjunction with plasmid p166AcV5-Se8 (22) as a template to introduce the R149-to-K149 mutation using high-fidelity Expand long-template PCR (Boehringer Mannheim). The PCR product was agarose gel purified, and the single strand containing the mutation at the 3′ end served as a 5′ mutagenic primer in a second PCR together with 3′ primer 5′-GAGAGGCACGGGCCACGAAAGG-3′. The second PCR product was cloned into pGEM-T (Promega) to generate pGEM-Se8(K149). Plasmids p166AcV5-Se8(K149) and p166AcV5-Se8(K149)GFP were obtained by exchanging the BamHI/StuI fragment of pGEM-Se8(K149) with those of p166AcV5-Se8 and p166AcV5-Se8GFP (22), respectively.

Production of polyclonal antibodies.

Proteins F1Δ580-665 and F2 were expressed in Escherichia coli Bl21 cells containing vector pET28-SeF1Δ580-676 or pET2-SeF2 and were purified as described previously (23). The proteins were concentrated using a Centriprep 10-kDa filter device (Amicon) and dialyzed against phosphate-buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4). Protein concentrations were determined with the Bio-Rad protein assay.

Two chickens were injected intramuscularly with either 200 μg of purified F1Δ580-665 or F2 protein using a water-in-oil adjuvant. The chickens were boosted after 4 weeks with 150 μg of purified protein. Two weeks after the booster, eggs were collected every day for 2 weeks. The egg yolk was diluted threefold (wt/wt) in PBS containing 5.25% polyethylene glycol 6000 (PEG-6000) and 0.05% NaN3. The mixture was centrifuged for 15 min at 2,250 × g. The supernatant was filtered through glass wool, and PEG-6000 was added until 12% (wt/vol) was reached. After centrifugation for 15 min at 2,250 × g, the pellet was dissolved in water and centrifuged as before to remove debris. PEG-6000 was added to the solution until 12% (wt/vol) was reached, and centrifugation for 20 min at 2,250 × g was performed. The pellet containing polyclonal antibodies against fusion protein subunit F1 (α-F1) or F2 (α-F2) was dissolved in 2.5 ml of 0.9% NaCl per egg and stored at −20°C.

Purification of SeMNPV BV and ODV.

Hemolymph-derived BVs were purified from SeMNPV-infected S. exigua fourth-instar larvae as described previously (22) with some modifications. Briefly, 3 days postinfection (p.i.) hemolymph was collected and clarified at 2,000 × g for 10 min at 4°C. The supernatant was passed through a 0.45-μm-pore-size filter. BVs in the filtrate were pelleted through a 25% (wt/wt) sucrose cushion made up in 0.1× TE (10 mM Tris-HCl [pH 7.5], 1.0 mM EDTA) by centrifugation at 100,000 × g for 90 min at 4°C and resuspended in 0.1× TE. BVs from cell culture supernatants were purified in a similar fashion. Se301 cells were infected with 0.1 50% tissue culture infective dose (TCID50) of SeMNPV/cell. Seventy-two hours p.i. cell culture supernatants were clarified at 2,000 × g for 10 min at 4°C and passed through a 0.45-μm-pore-size filter. BVs in the filtrate were pelleted and resuspended as described above. ODVs were purified from polyhedra derived from SeMNPV-infected S. exigua fourth-instar larvae as described previously (22). The purity and integrity of BVs and ODVs were checked by electron microscopy.

Western blot analysis.

For electrophoresis under reducing conditions purified SeMNPV ODVs and BVs were disrupted in Laemmli buffer (125 mM Tris-HCl, 2% sodium dodecyl sulfate [SDS], 5% 2-mercaptoethanol, 10% glycerol, 0.001% bromophenol blue, pH 6.8). For electrophoresis under nonreducing conditions virions were disrupted in 125 mM Tris-HCl-8% SDS-37.5 mM iodoacetamide-10% glycerol-0.001% bromophenol blue, pH 6.8. Samples were denatured for 10 min at 95°C. Proteins were electrophoresed in SDS-polyacrylamide gels and transferred onto Immobilon-P membranes (Millipore) by semidry electrophoresis transfer (2). Membranes were blocked overnight at 4°C in PBS containing 2% milk powder, followed by incubation for 1 h at room temperature (RT) with antiserum at a dilution of 1:1,000 in PBS containing 0.2% milk power. After being washed three times for 15 min in PBS-T (PBS containing 0.1% Tween 20), the membranes were incubated for 1 h at RT with horseradish peroxidase conjugated with rabbit anti-chicken immunoglubulin (Sigma) diluted 1:50,000 in PBS containing 0.2% milk powder. After three washes for 15 min in PBS-T, the signal was detected by ECL technology as described by the manufacturer (Amersham).

Furin inhibition assay.

Se301 cells (2.0 × 105) were infected with 10 TCID50s of SeMNPV or AcMNPV/cell. At 2 h p.i. cells were washed twice with medium and incubated with medium containing a 50 μM concentration of furin cleavage inhibitor decanoylated arginyl-valyl-lysyl-arginyl chloromethylketone (dec-RVKR-cmk) (Bachem). The AcMNPV-infected cells were incubated without dec-RVKR-cmk. Cell culture supernatants were collected at 48 h p.i, and infectious BV was quantified by a TCID50 assay (35) on Se301 cells. The SeMNPV-infected cells were washed three times with medium without FBS and assayed for the presence of active fusion proteins in the plasma membrane by a syncytium formation assay as described below.

Syncytium formation assay.

Syncytium formation assays were performed by transfection of 5.0 × 105 Sf21 cells with 5 μg of DNA of p166AcV5-Se8 or p166AcV5-Se8(K149) using CellFECTIN (Gibco-BRL). Empty vector p166BRNX-AcV5 (22) was used as a negative control for the syncytium formation assay. Forty-eight hours after transfection, cells were washed three times with medium without FBS and treated for 2 min in acidic medium without FBS, pH 5.0. The acidic medium was replaced with medium with FBS, pH 6.1. Syncytium formation was recorded by light microscopy 4 h after treatment with the acidic medium. Syncytium formation was positive when at least four nuclei were present in each syncytial mass.

Fluorescence microscopy.

To investigate the cellular location of the mutant SeMNPV F protein, 1.0 × 105 Sf21 cells were grown on glass coverslips and transfected with 5 μg of DNA of p166AcV5-Se8GFP or p166AcV5-Se8(K149)GFP. As a control for green fluorescent protein (GFP), expression plasmid p166AcV5-GFP (22) was used. At 48 h posttransfection the localization of GFP in the cells was examined with a Zeiss LSM510 (confocal) laser scanning microscope for fluorescence using an excitation wavelength of 488 nm and an emission bandpass filter of 505 to 530 nm.

Computer-assisted analysis.

The SeMNPV F protein was analyzed for several protein motifs using different bioinformation programs. N-terminal signal sequences were found with program PSORT II (National Institute for Basic Biology [http://www.nibb.ac.jp]). Possible coiled-coil regions in the protein were predicted using the program PairCoil (version 1.0; MIT Laboratory for Computer Science [http://www.lcs.mit.edu]). Comparisons between the SeMNPV F protein and other viral fusion proteins were done with program FASTA (version 3; EMBL-European Bioinformatics Institute [http://www.ebi.ac.uk]). Sequence alignments were performed with program ClustalW (EMBL-European Bioinformatics Institute [http://www.ebi.ac.uk]).

RESULTS

Inhibition of furin-mediated cleavage.

ORF8 (Se8) of SeMNPV was recently shown to encode the viral fusion (F) protein. A 60-kDa C-terminal subunit (F1) of the primary Se8 translation product was present in the envelopes of BVs, which were purified from hemolymph of infected S. exigua larvae (22). Amino acid sequence RSKR immediately upstream of the N terminus of 60-kDa subunit F1 is consistent with a consensus cleavage site of furin-like endoproteases (22), and this suggests that F1 is a cleavage product of a precursor, F0, of the envelope fusion protein. To demonstrate that F0 is subjected to proteolytic cleavage by furin and that cleavage is important for infectivity, furin inhibitor dec-RVKR-cmk was used. This inhibitor penetrates into cells and specifically binds to the catalytic site of furin (10, 15, 40, 47) and thus may inhibit the production of infectious SeMNPV BV.

Supernatants of SeMNPV-infected Se301 cells (48 h p.i.), grown in the presence or absence of dec-RVKR-cmk (50 μM), were assayed for the amount of infectious progeny BV by determining TCID50s. In the presence of the furin inhibitor the virus titer was reduced dramatically to 2% of the titer for the control (absence of the inhibitor) (Fig. 1, lanes 1 and 2). This drop could be caused by either distortion in the BV assembly pathway, giving no new progeny BVs, or by progeny BVs that are not infectious anymore due to the presence of uncleaved fusion proteins (F0) in their envelopes. In a similar experiment with AcMNPV the furin inhibitor had no effect on the virus titer (Fig. 1, lanes 3 and 4), indicating that the furin inhibitor did not affect the formation of BV per se.

FIG. 1.

FIG. 1.

Effect of furin inhibitor dec-RVKR-cmk on SeMNPV and AcMNPV BV infectivity. Se301 cells were infected with SeMNPV (lanes 1 and 2) or AcMNPV (lanes 3 and 4) in the presence (lanes 2 and 4) or absence (lanes 1 and 3) of furin inhibitor dec-RVKR-cmk. At 48 h p.i. the titer of progeny infectious BV in the cell culture supernatants was determined by TCID50 assays. The data presented are means and standard deviations of three independent experiments.

To exclude the possibility that the drop in SeMNPV virus titer was due to an impairment of the SeMNPV BV assembly pathway, progeny BVs were isolated from cell cultures incubated in the presence or absence of dec-RVKR-cmk. Western analysis with polyclonal antibodies against F1 (α-F1) revealed the presence of a 60-kDa protein (F1) in both BV preparations (Fig. 2, lanes 1 and 2). BV obtained from cell cultures incubated in the presence of the furin inhibitor possessed an additional 80-kDa protein (F0) (Fig. 2, lane 2). These experiments showed that blocking the furin-mediated cleavage of F0 did not impair the assembly of BVs.

FIG. 2.

FIG. 2.

Western blot analysis of proteins obtained from SeMNPV BV, produced in the absence (−; lane 1) or presence (+ lane 2) of furin inhibitor dec-RVKR-cmk. BVs were incubated for 10 min at 95°C in Laemmli buffer and subjected to SDS-PAGE (12% polyacrylamide). Proteins were transferred onto an Immobilon-P membrane (Millipore), incubated with α-F1, and detected with a chemiluminescent substrate. Size standards in kilodaltons are on the left. F0, precursor SeMNPV F protein; F1, 60-kDa subunit of SeMNPV F protein.

SeMNPV F protein with mutated cleavage site is unable to trigger fusion.

Previously, it was demonstrated that acidification of the medium of SeMNPV-infected Se301 cells resulted in syncytium formation (22). To determine whether inhibition of furin-mediated cleavage would also inhibit activation of membrane fusion activity by the F protein, Se301 cells were infected with SeMNPV in the presence of dec-RVKR-cmk. After a pH drop to 5.0, cells were examined for their ability to form syncytia (48 h p.i.). Control cells infected in the absence of the furin inhibitor showed cell-to-cell fusion (Fig. 3A), whereas in the presence of the furin inhibitor cell-to-cell fusion was not observed (Fig. 3B). This suggests that uncleaved precursor F0 is unable to trigger cell-to cell fusion.

FIG. 3.

FIG. 3.

SeMNPV-mediated fusion of Se301 cells. Cells were infected with SeMNPV in the absence (A) or presence (B) of furin inhibitor dec-RVKR-cmk. Forty-eight hours p.i. cells were incubated for 2 min with medium, pH 5.0. Syncytium formation was scored 4 h after dropping the pH by phase-contrast microscopy.

To obtain direct evidence that the F0 protein of SeMNPV has no fusogenic activity, consensus furin cleavage site RSKR of the F protein was mutated by changing the arginine (R) at amino acid residue 149 (upstream of the cleavage site) into a lysine (K). Whether the mutant FK149 protein could be transported to the plasma membrane was examined first. Sf21 cells instead of Se301 cells (Se301 cells are difficult to transfect, and cell-to-cell fusion is difficult to monitor due to the multimorphic cell phenotypes found in this cell line) were transfected with plasmids containing either the wild-type F (p166AcV5-Se8GFP) or the mutant FK149 (p166AcV5-Se8(K149)GFP) open reading frame, which was fused C-terminally to GFP under the control of an optimized OpMNPV gp64 promoter to facilitate expression in insect cells (3). Both wild-type F and mutant FK149 proteins were predominantly localized in the plasma membrane 48 h after the transfection (Fig. 4A and B). The GFP protein alone (p166AcV5-GFP) showed a homogeneous fluorescence signal in the cytoplasm and nuclei of Sf21 cells (Fig. 4C), suggesting that the mutation does not affect the transport of the F protein to the plasma membrane.

FIG. 4.

FIG. 4.

Localization studies with SeMNPV wild-type F and mutant FK149-GFP fusion proteins (A to C) and their ability to mediate cell-to-cell fusion in Sf21 cells (D to F). For the localization studies, Sf21 cells were transfected with plasmid p166AcV5-Se8GFP (A), p166AcV5-Se8(K149)GFP (B), or control plasmid p166AcV5-GFP (C). Fluorescence was examined 48 h after transfection by confocal laser scanning microscopy. For pH-dependent membrane fusion, Sf21 cells were transfected with plasmid p166AcV5-Se8 (D), p166AcV5-Se8(K149) (E), or control p166BRNX-AcV5 (F). Forty-eight hours after transfection, cells were treated for 2 min with medium, pH 5.0. Four hours after the pH drop syncytium formation was scored by phase-contrast microscopy.

To examine whether the FK149 protein is able to trigger cell-to-cell fusion upon lowering the pH of the medium, Sf21 cells were transfected with similar constructs without the C-terminal GFP fusion. Cells transfected with the wild-type F construct (p166AcV5-Se8) clearly showed pH-dependent cell-to-cell fusion (Fig. 4D). The FK149 protein [p166AcV5-Se8(K149)] did not trigger cell-to-cell fusion (Fig. 4E), similar to what was found for the cells transfected with the empty vector (p166BRNX-AcV5) (Fig. 4F). So, it is concluded that the SeMNPV F protein requires cleavage by furin to become active as a fusion protein.

SeMNPV BV contains both F protein subunits.

Cleavage of the F0 precursor yields, besides the 60-kDa C-terminal cleavage product (F1), a product of approximately 15 kDa (the N-terminal subunit minus the signal peptide; F2). Several proteins in the 15- to 17-kDa range from BVs purified from hemolymph of SeMNPV-infected S. exigua larvae have been reported (22).

To determine whether SeMNPV BV contains both mature F subunits (F1 and F2) and whether cleavage of the SeMNPV F0 protein occurs in tissue culture as well as in insects, BVs were purified from cell culture supernatants of SeMNPV-infected Se301 cells and from hemolymph obtained from SeMNPV-infected S. exigua larvae. Western analysis with polyclonal antibodies against F1 (α-F1) revealed the presence of a 60-kDa protein in BVs obtained from hemolymph as well as from cell culture (Fig. 5, lanes 1 and 2). Polyclonal antibodies specific against F2 (α-F2) detected a 21-kDa protein in both BV preparations (Fig. 5, lanes 4 and 5). Neither antibodies against F1 nor antibodies against F2 reacted with ODV-derived proteins (Fig. 5, lanes 3 and 6), demonstrating that both F protein subunits are BV specific.

FIG. 5.

FIG. 5.

Western blot analysis of reduced proteins of SeMNPV virus preparations. Cell culture-derived (CC) BVs, hemolymph-derived (He) BVs, and polyhedra-derived ODVs were incubated for 10 min at 95°C in Laemmli buffer and subjected to SDS-PAGE (12% polyacrylamide). Proteins were transferred onto an Immobilon-P membrane (Millipore), incubated with either α-F1 (left) or α-F2 (right) antibodies, and detected with a chemiluminescent substrate. Size standards in kilodaltons are on the left. F1, 60-kDa subunit of SeMNPV F protein; F2, 21-kDa subunit of SeMNPV F protein.

Processing and oligomerization of the SeMNPV F protein.

The observation that both subunits, F1 and F2, were present in SeMNPV BV raised the question of whether these subunits interacted with each other. There is a possibility that these subunits remain noncovalently associated, as found for the fusion protein of the Retroviridae (Env) (49), or are covalently associated by disulfide linkage, as found for fusion proteins in members of the Orthomyxoviridae (HA), Herpesviridae (gB), and Paramyxoviridae (F) (28, 29, 42).

To determine the type of interaction between F1 and F2, SeMNPV BV proteins were treated with iodoacetamide, which alkylates free sulfhydryl groups and thereby prevents artificial disulfide exchange during further treatment or electrophoresis (14). The proteins were denatured in the absence of reducing agents and electrophoresed in a 12% polyacrylamide gel. Western analysis with α-F1 and α-F2 detected in both cases a single protein with a molecular mass of 80 kDa (F1,2) (Fig. 6A, lanes 1 and 2). The absence of free F1 and F2 indicates that these subunits remain covalently linked after cleavage.

FIG. 6.

FIG. 6.

Western blot analysis of nonreduced proteins of SeMNPV BV. Cell culture-derived BVs were incubated for 10 min at 95°C in the presence of 37.5 mM iodoacetamide and in the absence of 2-mercaptoethanol and electrophoresed in a 12% (A) or 6% (B) SDS-polyacrylamide gel. Proteins were transferred onto an Immobilon-P membrane (Millipore), incubated with either α-F1 or α-F2, and detected with a chemiluminescent substrate. Size standards (kilodaltons) are indicated. F1,2, 60- and 21-kDa disulfide-linked subunits of SeMNPV F protein.

To investigate whether F proteins from SeMNPV also form disulfide-linked oligomers, a nonreducing SDS-polyacrylamide gel electrophoresis (PAGE) was performed using a 6% polyacrylamide gel. Antibodies α-F1 and α-F2 detected a major monomeric form of 80 kDa (Fig. 6B, lanes 1 and 2). Antibody α-F2 detected also a possible dimeric form as a minor band of 155 kDa (Fig. 6B, lane 2); higher multimeric forms were not detected.

DISCUSSION

Posttranslational cleavage of fusion proteins of enveloped viruses seems to represent a general mechanism used to regulate viral membrane fusion activity. All members of the Orthomyxoviridae, Paramyxoviridae, Togoviridae, Coronaviridae, Retroviridae, and Herpesviridae express their fusion proteins as a precursors, which have to be cleaved by host proteases to render infectious virus (25). The cleavage usually takes place in front of a hydrophobic sequence, the fusion peptide. Exposure to low pH or binding to a receptor triggers a conformational change in which the fusion peptide is believed to translocate and insert itself into the target membrane (25).

In this report it is demonstrated that SeMNPV, a representative of a group II NPV within the Baculoviridae, also expresses its fusion protein as precursor F0. This precursor is posttranslationally cleaved by insect cell furin into two disulfide-linked subunits, F1 and F2, to become active in tissue culture and in insects. The major envelope protein of HaSNPV BV, the product of Ha133, has also been identified and characterized (7; M. Westenberg and H. Z. Wang, personal communication). This protein turned out to be also a C-terminal cleavage product of the SeMNPV F protein homolog. In contrast to the SeMNPV and HaSNPV F proteins, the LdMNPV BV F protein was reported not to be cleaved (37), despite the fact that it possesses a similar furin cleavage site at a position analogous to those in SeMNPV and HaSNPV. An 83-kDa fusion protein was detected in LdMNPV BV purified from cell culture supernatants. Tunicamycin treatment of the cells resulted in an LdMNPV fusion protein with a molecular mass of 72 kDa. The latter value is consistent with a predicted molecular mass of 75 kDa for the product of the whole open reading frame minus the signal sequence (residues 1 to 16). Therefore it is most likely that Ld625Y cells are unable to properly cleave the fusion protein from LdMNPV BV. However the titers of progeny BVs from Ld625Y cells are even higher (41) than that of SeMNPV in Se301 cells. So it is very possible that the activation of the fusion protein of LdMNPV during viral uptake by Ld625Y cells is similar to the activation of the influenza virus A/WSN/33 (H1N1) fusion protein in vertebrate cells. This virus possesses only the uncleaved HA, which is cleaved during uptake presumably by an endosomal protease (6).

The cleavage of the F0 protein by furin was demonstrated by the use of a furin inhibitor at a concentration of 50 μM, which seemed to be the most effective concentration (data not shown). The titers of the progeny BVs produced in the presence of the inhibitor were about 2% of the control titers (Fig. 1). The 2% residual infectious virus is in agreement with similar findings with other viral systems (15, 36, 40) and is probably the result of the instability of the furin inhibitor in aqueous solutions. However, we cannot exclude the possibility that a small proportion of the F0 protein is cleaved by another unknown protease. Infected cells were also unable to form syncytia in the presence of the inhibitor (Fig. 3), which is consistent with earlier reports that cell-to-cell fusion after viral infection could be completely blocked by peptidyl-chloroalkylketones (15, 47). BV assembly was not impaired in the presence of the furin inhibitor (Fig. 2). Nevertheless the amount of F1 protein relative to the amount of F0 protein is not proportional to the drop in virus titer but is in agreement with similar findings for influenza virus, where the cleavage inhibition of HA0 was also not proportional to the drop in hemagglutination titer (47). For influenza viruses and group I NPVs it has been shown that at least three HA trimers (5, 8) and approximately six GP64 trimers (38), respectively, cooperate in the formation of the fusion pore. So, the presence of even small amounts of F0 in BVs can interfere with the mature fusion proteins in the fusion process.

Cleavage products F1 and F2 are covalently associated, similar to the fusion proteins of members of the Orthomomyxoviridae, Herpesviridae, and Paramyxoviridae (28, 29, 42). The F2 subunit of SeMNPV contains only a single cysteine residue (C94), which makes this cysteine the only candidate to form the disulfide bridge with F1. This cysteine residue is conserved among the F protein homologs of HaSNPV (6) and LdMNPV (26). In contrast, the F1 subunit contains 15 cysteine residues. Ten of these are situated upstream of the predicted transmembrane region, and 9 of the 10 are conserved among the group II NPVs (SeMNPV, LdMNPV, HaSNPV). The molecular mass of the F1 subunit (60 kDa) is in close agreement with the molecular mass of 59 kDa predicted from the DNA sequence. The F2 subunit was detected by SDS-PAGE as a 21-kDa peptide (Fig. 5). Upon maturation the F2 subunit might go through some posttranslational modification processes, including N-glycosylation and O-glycosylation (22), which may explain the difference between the theoretical (15 kDa) and actual (21 kDa) sizes of this subunit.

Viral fusion proteins generally form higher-order oligomers (18). In most cases these oligomers are formed by noncovalent interactions. However, envelope fusion protein GP64 of group I NPVs forms a trimer of disulfide-linked monomers (34). The F protein of SeMNPV was predominantly present as a monomer (Fig. 6B). A minor band approximately twice the size of the monomer was also detected. Although this band could represent a dimeric form of the protein, most likely this is due to incomplete denaturation, since this band was only detected by α-F2. Furthermore, treatment of GP64 of AcMNPV under the same conditions resulted in the simultaneous occurrence of trimers together with minor dimers and monomers (data not shown). Therefore, it is concluded that disulfide links are most likely not involved in oligomerization of the F protein. The potential oligomeric structure of the SeMNPV F protein remains to be characterized.

The SeMNPV F protein is very similar in structure to the paramyxovirus fusion protein. Both consist of a small N-terminal subunit linked by a disulfide bridge to the large C-terminal membrane-anchored subunit. The SeMNPV F protein has the highest homology with paramyxovirus human respiratory syncytial virus fusion protein [P03420], with 12% amino acid identity and 36% similarity. Although the overall homology is not high (12%), predicted domains such as α-helices and β-sheets, as well as the furin cleavage sites, the heptad repeats (HRs), and the transmembrane regions, are structurally conserved. Furthermore, the fusion protein of the paramyxoviruses contains a fusion peptide, which is located at the N terminus of the large membrane-anchored subunit. We predict that the SeMNPV F protein contains a putative fusion peptide at an analogous position. Amino acids 150 to 166 GLFNFMGHVDKYLFGIM contain nine hydrophobic residues (underlined) with hydrophobicity indices (H.I.) higher than 0.62 according to the normalized consensus scale of Eisenberg (9). These hydrophobic residues can be modeled as a hydrophobic face in an α-helix. The average H.I. of the hydrophobic face is 1.1, and the total amino acid stretch has a H.I. of 0.5, which is consistent with those for other viral fusion proteins (55).

The paramyxovirus fusion proteins contain HRs (HR1 and HR2) immediately adjacent to the fusion peptide and the transmembrane domain (27). Previous studies with other viral fusion proteins suggested that these HRs form trimeric hairpin-like structures, with the HR2 regions packing in an antiparallel manner against the inner coiled-coil formed by the HR1 regions. The likely role of the hairpin structure is to facilitate apposition of the viral and cellular membranes by bringing the fusion peptide, which inserts into the cellular membrane, close to the transmembrane segment, which is anchored in the viral membrane (44). The SeMNPV F protein also contains two putative HRs. The first HR is adjacent to the putative fusion peptide and is formed by amino acid residues 174 to 202 (HR1: LhmLantTnsLnsqVkqLndeLivLadyV, where the amino acids in uppercase are the nonpolar, hydrophobic residues). The second putative HR is adjacent to the transmembrane domain and is formed by amino acid residues 521 to 549 (HR2: VddMkinNdlEktnLheLtsrLydLrrrI). Further studies are in progress to confirm whether those motifs indeed are required for the fusion function.

Acknowledgments

Part of this research (W. F. J. IJkel) was supported by The Netherlands Foundation for Chemical Sciences (CW), with financial aid from The Netherlands Organization for Scientific Research (NWO). H. Wang was a recipient of a NUFFIC fellowship.

We thank D. Peters for immunization of chickens and providing us with antibody-containing eggs, G. W. Blissard for his advice throughout the research and critical reading of the manuscript, and W. Garten for his advice about the furin inhibitor.

REFERENCES

  • 1.Adams, J. R., and J. T. McClintock. 1991. Nuclear polyhedrosis viruses of insects, p. 87–204. In J. R. Adams and J. R. Bonami (ed.), Atlas of invertebrate viruses. CRC Press, Boca Raton, Fla.
  • 2.Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1994. Current protocols in molecular biology. Greene Publishing Associates and Wiley Interscience, New York, N.Y.
  • 3.Blissard, G. W., and G. F. Rohrmann. 1991. Baculovirus gp64 gene expression: analysis of sequences modulating early transcription and transactivating by IE1. J. Virol. 65:5820–5827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Blissard, G. W., and J. R. Wenz. 1992. Baculovirus gp64 envelope glycoprotein is sufficient to mediate pH-dependent membrane fusion. J. Virol. 66:6829–6835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Blumenthal, R., D. P. Sarkar, S. Durell, D. E. Howard, and S. J. Morris. 1996. Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events. J. Cell Biol. 35:63–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Boycott, R., H. D. Klenk, and M. Ohuchi. 1994. Cell tropism of influenza virus mediated by hemagglutinin activation at the stage of virus entry. Virology 203:313–319. [DOI] [PubMed] [Google Scholar]
  • 7.Chen, X., F. F. J. IJkel, R. Tarchini, X. Sun, H. Sandbrink, H. Wang, S. Peters, D. Zuidema, R. K. Lankhorst, J. M. Vlak, and Z. Hu. 2001. The sequence of the Helicoverpa armigera single nucleocapsid nucleopolyhedrovirus genome. J. Gen. Virol. 82:241–257. [DOI] [PubMed] [Google Scholar]
  • 8.Danieli, T., S. L. Pelletier, Y. L. Henis, and J. M. White. 1996. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers. J. Cell Biol. 133:559–569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Eisenberg, D. 1984. Three-dimensional structure of membrane and surface proteins. Annu. Rev. Biochem. 53:595–623. [DOI] [PubMed] [Google Scholar]
  • 10.Garten, W., A. Stieneke, E. Shaw, P. Wikstrom, and H. D. Klenk. 1989. Inhibition of proteolytic activation of influenza virus hemagglutinin by specific peptidyl chloroalkyl ketones. Virology 172:25–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Gelernter, W. D., and B. A. Federici. 1986. Isolation, identification and determination of virulence of a nuclear polyhedrosis virus from the beet armyworm Spodoptera exigua (Lepidoptera: Noctuidae). Environ. Entomol. 15:240–245. [Google Scholar]
  • 12.Granados, R. R. 1978. Early events in the infection of Heliothis zea midgut cells by a baculovirus. Virology 90:170–174. [DOI] [PubMed] [Google Scholar]
  • 13.Granados, R. R., and K. A. Lawler. 1981. In vivo pathway of Autographa californica baculovirus invasion and infection. Virology 108:297–308. [DOI] [PubMed] [Google Scholar]
  • 14.Gray, W. R. 1997. Disulfide bonds between cysteine residues, p. 165–186. In T. E. Creighton (ed.), Protein structure: a practical approach. Oxford University Press, Oxford, United Kingdom.
  • 15.Hallenberger, S., V. Bosch, H. Angliker, E. Shaw, H. D. Klenk, and W. Garten. 1992. Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature 360:358–361. [DOI] [PubMed] [Google Scholar]
  • 16.Hara, K., M. Funakoshi, and T. Kawarabata. 1995. A cloned cell line of Spodoptera exigua has a highly increased susceptibility to the Spodoptera exigua nuclear polyhedrosis virus. Can. J. Microbiol. 41:1111–1116. [Google Scholar]
  • 17.Hefferon, K. L., A. G. Oomens, S. A. Monsma, C. M. Finnerty, and G. W. Blissard. 1999. Host cell receptor binding by baculovirus GP64 and kinetics of virion entry. Virology 258:455–468. [DOI] [PubMed] [Google Scholar]
  • 18.Hernandez, L. D., L. R. Hoffman, T. G. Wolfsberg, and J. M. White. 1996. Virus-cell and cell-cell fusion. Annu. Rev. Cell Dev. Biol. 12:627–661. [DOI] [PubMed] [Google Scholar]
  • 19.Horton, H. M., and J. P. Burand. 1993. Saturable attachment sites for polyhedron-derived baculovirus on insect cells and evidence for entry via direct membrane fusion. J. Virol. 67:1860–1868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hosaka, M., M. Nagahama, W. S. Kim, T. Watanabe, K. Hatsuzawa, J. Ikemizu, K. Murakami, and K. Nakayama. 1991. Arg-X-Lys/Arg-Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretory pathway. J. Biol. Chem. 266:12127–12130. [PubMed] [Google Scholar]
  • 21.IJkel, W. F. J., E. A. Van Strien, J. G. Heldens, R. Broer, D. Zuidema, R. W. Goldbach, and J. M. Vlak. 1999. Sequence and organization of the Spodoptera exigua multicapsid nucleopolyhedrovirus genome. J. Gen. Virol. 80:3289–3304. [DOI] [PubMed] [Google Scholar]
  • 22.IJkel, W. F. J., M. Westenberg, R. W. Goldbach, G. W. Blissard, J. M. Vlak, and D. Zuidema. 2000. A novel baculovirus envelope fusion protein with a proprotein convertase cleavage site.Virology 275:30–41. [DOI] [PubMed] [Google Scholar]
  • 23.IJkel, W. F. J., R.-J. Lebbink, M. L. Op den Brouw, R. W. Goldbach, J. M. Vlak, and D. Zuidema. 2001. Identification of a novel occlusion derived virus-specific protein in Spodoptera exigua multicapsid nucleopolyhedrosisvirus. Virology 284:170–181. [DOI] [PubMed] [Google Scholar]
  • 24.Kingsley, D. H., A. Behbahani, A. Rashtian, G. W. Blissard, and J. Zimmerberg. 1999. A discrete stage of baculovirus GP64-mediated membrane fusion. Mol. Biol. Cell 10:4191–4200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Klenk, H. D., and W. Garten. 1994. Activation of viral spike proteins by host proteases, p. 241–280. In E. Wimmer (ed.), Cellular receptors for animal viruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
  • 26.Kuzio, J., M. N. Pearson, S. H. Harwood, C. J. Funk, J. T. Evans, J. M. Slavicek, and G. F. Rohrmann. 1999. Sequence and analysis of the genome of a baculovirus pathogenic for Lymantria dispar. Virology 253:17–34. [DOI] [PubMed] [Google Scholar]
  • 27.Lamb, R. A. 1993. Paramyxovirus fusion: a hypothesis for changes. Virology 197:1–11. [DOI] [PubMed] [Google Scholar]
  • 28.Lazarowitz, S. G., R. W. Compans, and P. W. Choppin. 1971. Influenza virus structural and non-structural proteins in infected cells and their plasma membrane. Virology 46:830–843. [DOI] [PubMed] [Google Scholar]
  • 29.Meyer, H., Y. Masuho, and M. Mach. 1990. The gp116 of the gp58/116 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitope. J. Gen. Virol. 71:2443–2450. [DOI] [PubMed] [Google Scholar]
  • 30.Monsma, S. A., A. G. P. Oomens, and G. W. Blissard. 1996. The GP64 envelope fusion protein is an essential baculovirus protein required for cell-to-cell transmission of infection. J. Virol. 70:4607–4616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Muñoz, D., J. I. Castillejo, and P. Caballero. 1998. Naturally occurring deletion mutants are parasitic genotypes in a wild-type nucleopolyhedrovirus population of Spodoptera exigua. Appl. Environ. Microbiol. 64:4372–4377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Nakayama, K. 1997. Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. J. Biochem. 327:625–635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Oomens, A. G. P., and G. W. Blissard. 1999. Requirement for GP64 to drive efficient budding of Autographa californica multicapsid nucleopolyhedrovirus. Virology 254:297–314. [DOI] [PubMed] [Google Scholar]
  • 34.Oomens, A. G. P., S. A. Monsma, and G. W. Blissard. 1995. The baculovirus GP64 envelope fusion protein: synthesis, oligomerization, and processing. Virology 209:592–603. [DOI] [PubMed] [Google Scholar]
  • 35.O’Reilly, D. R., L. K. Miller, and V. A. Luckow. 1992. Baculovirus expression vectors, a laboratory manual. W. H. Freeman and Co., New York, N.Y.
  • 36.Ortmann, D., M. Ohuchi, H. Angliker, E. Shaw, W. Garten, and H. D. Klenk. 1994. Proteolytic cleavage of wild type and mutants of the F protein of human parainfluenza virus type 3 by two subtilisin-like endoproteases, furin and Kex2. J. Virol. 68:2772–2776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Pearson, M. N., C. Groten, and G. F. Rohrmann. 2000. Identification of the Lymantria dispar nucleopolyhedrovirus envelope fusion protein provides evidence for a phylogenetic division of the Baculoviridae. J. Virol. 74:6126–6131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Plonsky, I., and J. Zimmerberg. 1996. The initial fusion pore induced by baculovirus GP64 is large and forms quickly. J. Cell Biol. 135:1831–1839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Plonsky, I., M. S. Cho, A. G. P. Oomens, G. W. Blissard, and J. Zimmerberg. 1999. An analysis of the role of the target membrane on the GP64-induced fusion pore. Virology 253:65–76. [DOI] [PubMed] [Google Scholar]
  • 40.Richt, J. A., T. Fürbringer, A. Koch, I. Pfeuffer, C. Herden, I. Bause-Niedrig, and W. Garten. 1998. Processing of the Borna disease virus glycoprotein gp94 by the sutilisin-like endoprotease furin. J. Virol. 72:4528–4533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Riegel, C. I., and J. M. Slavicek. 1997. Characterization of the replication cycle of the Lymantria dispar nuclear polyhedrosis virus. Virus Res. 51:9–17. [DOI] [PubMed] [Google Scholar]
  • 42.Schied, A., and P. W. Choppin. 1977. Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses. Virology 80:54–66. [DOI] [PubMed] [Google Scholar]
  • 43.Sharrocks, A. D., and P. E. Shaw. 1992. Improved primer design for PCR-based, site-directed mutagenesis. Nucleic Acids Res. 20:1147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Singh, M., B. Berger, and P. S. Kim. 1999. LearnCoil-VMF: computational evidence for coiled-coil-like motifs in many viral membrane-fusion proteins. J. Mol. Biol. 290:1031–1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Smith, G. E., and M. D. Summers. 1978. Analysis of baculovirus genomes with restriction endonucleases. Virology 89:517–527. [DOI] [PubMed] [Google Scholar]
  • 46.Smits, P. H., and J. M. Vlak. 1988. Quantitative and qualitative aspects in the production of a nuclear polyhedrosis virus in Spodoptera exigua larvae. Ann. Appl. Biol. 112:249–257. [Google Scholar]
  • 47.Stieneke-Gröber, A., M. Vey, H. Angliker, E. Shaw, G. Thomas, C. Roberts, H. D. Klenk, and W. Garten. 1992. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J. 11:2407–2414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Vaughn, J. L., R. H. Goodwin, G. J. Tompkins, and P. McCawley. 1977. The establishment of two cell lines from the insect Spodoptera frugiperda (Lepidoptera; Noctuidae). In Vitro 13:213–217. [DOI] [PubMed] [Google Scholar]
  • 49.Veronese, F. D., A. L. DeVico, T. D. Copeland, S. Oroszlan, R. C. Gallo, and M. G. Sarngadharan. 1985. Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene. Science 229:1402–1405. [DOI] [PubMed] [Google Scholar]
  • 50.Vey, M., W. Schäfer, B. Reis, R. Ohuchi, W. Britt, W. Garten, H. D. Klenk, and K. Radsak. 1995. Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediated by the human endoprotease furin. Virology 206:746–749. [DOI] [PubMed] [Google Scholar]
  • 51.Vey, M., W. Schäfer, S. Berghöfer, H. D. Klenk, and W. Garten. 1994. Maturation of the trans-Golgi network protease furin: compartmentalization of propeptide removal, substrate cleavage, and COOH-terminal truncation. J. Cell Biol. 127:1829–1842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Volchkov, V. E., H. Feldmann, A. V. Volchkova, and H. D. Klenk. 1998. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc. Natl. Acad. Sci. USA 95:5762–5767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Volkman, L. E., and M. D. Summers. 1977. Autographa californica nuclear polyhedrosis virus: comparitive infectivity of the occluded, alkali-liberated, and nonoccluded forms. J. Invertebr. Pathol. 30:102–103. [DOI] [PubMed] [Google Scholar]
  • 54.Volkman, L. E., and P. A. Goldsmith. 1985. Mechanism of neutralization of budded Autograpa californica nuclear polyhedrosis virus by a monoclonal antibody: inhibition of entry by adsorptive endocytosis. Virology 143:185–195. [DOI] [PubMed] [Google Scholar]
  • 55.White, J. M. 1992. Membrane fusion. Science 258:917–924. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES